Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Asthma and tobacco].

N Gusbin1, N Garzaniti, R Louis

  • 1Pneumologue, Centre Hospitalier Hutois.

Revue Medicale De Liege
|March 29, 2006
PubMed
Summary

Smoking asthmatics represent a distinct patient group with more severe symptoms and altered airway inflammation. Their condition often shows resistance to standard treatments, highlighting the need for new therapies and smoking cessation support.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Synbiotic Bactecal® reduces airway obstruction, sputum eosinophils and IL-4 but increases sputum IL-8 in patients with uncontrolled asthma" [Cytokine 202 (2026) 157145].

Cytokine·2026
Same author

Synbiotic Bactecal® reduces airway obstruction, sputum eosinophils and IL-4 but increases sputum IL-8 in patients with uncontrolled asthma.

Cytokine·2026
Same author

Author Correction: Forced oscillation technique in progressive pulmonary fibrosis in a single-center retrospective study.

Scientific reports·2026
Same author

Forced oscillation technique in progressive pulmonary fibrosis in a single-center retrospective study.

Scientific reports·2025
Same author

Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users.

Journal of investigational allergology & clinical immunology·2025
Same author

Increase in Blood Eosinophil Count Over Time and Sputum IL8 are Associated with FEV<sub>1</sub> Decline in Asthma.

Lung·2024

Area of Science:

  • Pulmonology and Respiratory Medicine
  • Clinical Immunology

Context:

  • Approximately 40% of individuals with asthma are current or former smokers.
  • Smoking asthmatics represent an understudied population with unique characteristics.
  • Tobacco use is a recognized risk factor for asthma exacerbation and progression.

Purpose:

  • To investigate the distinct phenotype of asthma in smokers compared to non-smokers.
  • To understand the differences in airway inflammation and clinical presentation.
  • To explore treatment resistance and identify alternative therapeutic strategies.

Summary:

  • Smoking asthmatics display a different phenotype characterized by distinct inflammatory profiles in the airways.
  • Clinically, asthma in smokers is more severe, with increased symptoms and functional impairment.
  • A key challenge is the observed resistance to inhaled corticosteroids, a primary asthma medication.

Impact:

  • Highlights the urgent need for alternative treatments for smoking-induced asthma.
  • Emphasizes the critical importance of smoking cessation programs for asthmatic patients.
  • Advances understanding of asthma heterogeneity and personalized treatment approaches.

Related Experiment Videos